AF
TEVA icon

Affiance Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Affiance Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,050
Closed -$219K – 87
2016
Q4 		$219K Hold
6,050
– – 0.18% 78
2016
Q3 		$278K Sell
6,050
-40
-0.7% -$2.09K 0.23% 67
2016
Q2 		$306K Sell
6,090
-26
-0.4% -$1.38K 0.26% 64
2016
Q1 		$327K Buy
6,116
+26
+0.4% +$1.53K 0.31% 62
2015
Q4 		$400K Hold
6,090
– – 0.41% 54
2015
Q3 		$344K Hold
6,090
– – 0.43% 53
2015
Q2 		$360K Hold
6,090
– – 0.46% 59
2015
Q1 		$379K Hold
6,090
– – 0.58% 51
2014
Q4 		$350K Buy
+6,090
New +$339K 0.61% 44

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Affiance Financial's TEVA Position: Q1 2017 in Review

Affiance Financial sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 6,050 shares — an estimated $219K sold.

Affiance Financial first reported a position in TEVA in Q4 2014 and held it in 9 quarters. The position peaked at $400K in Q4 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Affiance Financial reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Affiance Financial sold 6,050 Teva Pharmaceuticals shares in Q1 2017, an estimated $219K.
  • Affiance Financial first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 9 quarters.
  • Affiance Financial's Teva Pharmaceuticals position peaked at $400K in Q4 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Affiance Financial's 13F filing for Q1 2017, filed 8 Dec 2017.